InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Russell Angus C., Director. Insider active across 3 companies, notably Revance Therapeutics, Inc.. In total, 9 filings have been logged. Total volume traded: €178k. The latest transaction was filed on 4 May 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
06,059 shares0
Common Stock
SEC:0001479290-22-000059:0·
€89,0586,400 shares@ €13.9153100.0% of flow
Common Stock
SEC:0001479290-21-000173·
Ideal exit: 9 Sept 2022 (T+270)
€89,0586,400 shares@ €13.915350.0% of flow
Common Stock
SEC:0001479290-21-000173:0·
Ideal exit: 9 Sept 2022 (T+270)
96,864 shares
Common Stock
SEC:0001387131-21-008440·
96,864 shares
Common Stock
SEC:0001387131-21-008440:0·
€45,69324,720 shares@ €1.8484100.0% of flow
Common Shares, no par value
SEC:0001493152-21-015786·
€45,69324,720 shares@ €1.84840.011% mcap50.0% of flow
Common Shares, no par value
SEC:0001493152-21-015786:0·
04,013 shares0
Common Stock
SEC:0001479290-21-000114·
04,013 shares0
Common Stock
SEC:0001479290-21-000114:0·
9 of 9 declarations
About Russell Angus C.
Angus C. Russell serves as a Board Member at Revance Therapeutics, Inc., Lineage Cell Therapeutics, Inc., and TherapeuticsMD, Inc. He plays a key role in the governance of these companies, bringing his expertise in strategy and sustainability. His commitment to innovation and operational efficiency is essential for the success of the boards.
